TPX-0005,
Repotrectinib,
08O3FQ4UNP,
UNII-08O3FQ4UNP,
1802220-02-5,
Repotrectinib [USAN],
repotrectinib (proposed INN),
Repotrectinib (TPX-0005),
SCHEMBL16946804,
GTPL10316,
TPX0005,
TPX 0005 [WHO-DD],
EX-A2572,
TRX-0005,
s8583,
CS-7628,
example 93 [US20170334929A1],
HY-103022,
TPX-0005,2058227-19-1,TPX-0005,TPX 0005,TPX0005,
(13E,14E,3R,6S)-45-fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphan-9-one,
(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one,
1,15-Etheno-1H-pyrazolo(4,3-F)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-,
1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-,
NO,